Is 2% Lidocaine Viscous Safe for Oral Consumption?
2% lidocaine viscous can be used orally with extreme caution in adults and older children, but it carries significant risks of life-threatening toxicity—particularly in children under 3 years of age—and requires strict adherence to dosing limits and administration guidelines. 1
Critical Safety Warnings
The FDA drug label contains a black box warning specifically highlighting that postmarketing cases of seizures, cardiopulmonary arrest, and death have been reported in patients under 3 years of age when 2% lidocaine viscous was not administered according to strict dosing recommendations 1. Fatal intoxication cases have been documented in young children, with one 18-month-old infant experiencing cardiorespiratory arrest, seizures, and death after accidental ingestion 2.
High-Risk Populations
Children under 3 years:
- The product should generally NOT be used for teething pain 1
- Use only when safer alternatives are unavailable or have failed 1
- Concentrations >4% should never be used in children 3
Special considerations apply to:
- Infants <6 months (immature hepatic enzymes require lower doses) 3
- Patients with liver disease or heart failure 4
- Underweight patients 3
Safe Dosing Parameters
For Adults:
- Maximum infiltrative dose: 4.5 mg/kg without epinephrine 5
- Toxic symptoms typically occur when serum levels exceed 5 mg/mL or topical dose >7 mg/kg 4
- One study showed oral ingestion of 20 mL resulted in maximum serum level of only 0.55 μg/mL in adults with normal gastric function 6
For Children:
- Maximum topical dose: 5 mg/kg ideal body weight for procedures up to 2 hours 3
- Reduced dose of 4 mg/kg for infants <6 months, underweight children, or those with hepatic disease 3
- Use 1% or 2% solutions in children <10 kg (provides adequate volume and efficacy) 3
- Infiltrative maximum: 1.5-2.0 mg/kg without epinephrine 5
Clinical Toxicity Profile
Early neurotoxic symptoms appear at lower concentrations than cardiotoxic effects:
- Circumoral numbness, facial tingling 5
- Metallic taste, auditory changes 5
- Slurred speech, hallucinations 5
- Dizziness, euphoria 4
Progression to severe toxicity:
Critical caveat: Toxic symptoms can persist even after lidocaine concentrations decrease below therapeutic levels, likely due to active metabolites like MEGX (monoethylglycinexylidide) 2, 7. One case report documented continued toxicity despite serum lidocaine below toxic levels when using frequent applications 7.
Essential Safety Measures
Before administration:
- Calculate dose using ideal body weight, not actual weight 3
- Document total dose clearly in patient records 3
- Ensure 20% intravenous lipid emulsion is immediately available 3
During use:
- Use the lowest effective dose 5
- Avoid traumatized mucosa (increases systemic absorption) 1
- Never exceed recommended dosing intervals 1
After administration:
- Fast patients for at least 1 hour after oral/airway topicalization 3
- Extend fasting time if significant aspiration risk exists 3
- Monitor for signs of aspiration and systemic toxicity 3
- Duration of oral mucosal anesthesia may be <15 minutes 3
Efficacy Considerations
Interestingly, a randomized controlled trial found that 2% viscous lidocaine was not superior to flavored gel placebo in improving oral intake in children with painful infectious mouth ulcers 8. However, another study demonstrated significant pain reduction with 2% lidocaine cream compared to placebo in children with oral mucosal lesions 9. The analgesic effect typically lasts only 30 minutes to 1 hour 10, which is considerably shorter than alternatives like doxepin (>2 hours) 10.
Bottom Line Algorithm
Can it be used orally? Yes, but: